Cyproterone assists with regulation of hormone levels. Inhibiting specific hormone actions helps manage conditions that respond to changes in the body's natural chemical signals.
When hormone-related skin changes become noticeable, many people turn to medications that target excess androgen activity. Cyproterone belongs to the class of synthetic steroidal antiandrogens, meaning it works against male-type hormones that can affect the skin and other tissues. Its main therapeutic role is to reduce the effects of these hormones, helping to manage conditions like unwanted hair growth and acne. This active compound can be found in formulations such as Diane 35 and Cyproterone Acetate with Ethinylestradiol.
In Singapore, two common products list cyproterone as a key ingredient. Diane 35 is marketed as a combination tablet that pairs cyproterone acetate with the estrogen ethinylestradiol, while other products simply combine cyproterone acetate with the same estrogen. Both are typically supplied as oral tablets, although the exact dosage form may vary between brands. Generic versions carry the same active substance but may be labelled under different trade names.
Excessive facial hair growth is one of the visible signs that may lead a clinician to consider cyproterone. Acne that persists despite usual topical treatments is another scenario where the antiandrogen effect can be helpful. The compound is also used to address severe scalp hair loss linked to hormonal imbalance. In some cases, it forms part of hormonal therapy for certain women with polycystic ovary syndrome (PCOS) to control androgen-driven symptoms. Overall, it is most often prescribed for patients who need to reduce androgen activity.
The compound primarily blocks the effect of male hormones at the tissue level, preventing them from binding to their receptors. By doing so, it reduces the stimulation that leads to oil-producing skin glands and hair follicles. At the same time, cyproterone has a weak progestogenic effect, which can help balance hormone levels when combined with estrogen. This dual action assists in moderating symptoms without directly lowering hormone production.
Mild nausea, occasional headache, and temporary changes in menstrual flow are among the most frequently reported experiences. These reactions are usually short-lived and resolve without medical intervention.
Rare but important warning signs include sudden swelling of the face or throat, severe stomach pain, and yellowing of the skin or eyes. If any of these occur, urgent medical attention is required.
People who are pregnant, have a known allergy to cyproterone or related steroids, or have a history of blood clotting disorders should avoid using products that contain this ingredient. Individuals with severe liver disease should also exercise caution.
Alcohol and certain medication classes, such as anticoagulants or other hormonal agents, may interact with cyproterone. Readers should refer to the specific medication labeling or package information for exact interaction details.
Storing the tablets away from moisture helps maintain their stability, and keeping them out of reach of children is essential. Typical treatment periods can range from a few months to longer terms, depending on the condition being addressed. Differences in formulation, such as the presence of ethinylestradiol, may affect how the medication is taken. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of cyproterone and is not medical advice. Medicines containing this ingredient, such as Diane 35 and Cyproterone Acetate with Ethinylestradiol, may differ in formulation, strength, and directions. The information presented does not replace professional guidance, and liability for clinical decisions rests with the user. Readers should review the labeling of their specific medication and seek guidance from a healthcare professional.
Further reading and source material are listed below.
